Cancer Institute, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil.
J Surg Oncol. 2024 Sep;130(4):750-756. doi: 10.1002/jso.27746. Epub 2024 Jun 21.
Some studies have shown that gastrectomy performed by experienced surgeons in high-volume specialized hospitals with the possibility of complete treatment has better results. This study aimed to compare the results of patients who underwent surgery at a reference center with non-specialized centers.
Patients with gastric adenocarcinoma stage as pTNM II and III who underwent curative gastrectomy and were referred for adjuvant chemotherapy between 2009 and 2018 were included. Patients were divided into two groups: patients operated on in a reference center with complete oncological treatment (Reference Group); and those operated on in an external Hospital and referred for adjuvant treatment at the reference center (External Group).
A total of 643 patients were evaluated, 307 in the external group and 336 in the reference group. Patients in the external group were younger (58.9 vs. 62.6 years; p < 0.001) and with fewer comorbidities according to the Charlson-Deyo index (p < 0.001). The pathological result showed more dissected lymph nodes (41.4 vs. 23.5; p < 0.001) and a higher R0 resection rate (98.5% vs. 95.1%; p = 0.013) in the reference group. Patients of the external group underwent more adjuvant radiotherapy (49.5% vs. 33.9%; p < 0.001) with no difference concerning adjuvant chemotherapy (p = 0.066). Peritoneal recurrence was more common in the external group (63.2% vs 38.7%, p < 0.001). The disease-free survival rate was higher in the reference group (p < 0.001) as well as overall survival (p = 0.01).
Patients who received full oncological treatment at a reference center had better survival outcomes compared to those operated in external services.
一些研究表明,在高容量的专业医院中,由经验丰富的外科医生进行的、有可能实现完全治疗的胃切除术具有更好的效果。本研究旨在比较在参考中心和非专科医院接受手术的患者的结果。
纳入 2009 年至 2018 年间接受根治性胃切除术并转介辅助化疗的 pTNM II 和 III 期胃腺癌患者。患者分为两组:在提供完整肿瘤治疗的参考中心接受手术的患者(参考组);以及在外部医院接受手术并在参考中心接受辅助治疗的患者(外部组)。
共评估了 643 名患者,其中外部组 307 名,参考组 336 名。外部组患者年龄较小(58.9 岁 vs. 62.6 岁;p<0.001),根据 Charlson-Deyo 指数,合并症较少(p<0.001)。病理结果显示参考组的淋巴结清扫更多(41.4 个 vs. 23.5 个;p<0.001),R0 切除率更高(98.5% vs. 95.1%;p=0.013)。外部组患者接受更多的辅助放疗(49.5% vs. 33.9%;p<0.001),而辅助化疗无差异(p=0.066)。外部组的腹膜复发更为常见(63.2% vs. 38.7%,p<0.001)。参考组的无病生存率更高(p<0.001),总生存率也更高(p=0.01)。
在参考中心接受完整肿瘤治疗的患者的生存结果优于在外部服务机构接受手术的患者。